Bristol Myers Squibb Income Statement

BMY / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)

Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.

Bristol Myers Squibb reported $48.2B in revenue and $7.1B in net income for FY2025. Revenue has grown at a 6.0% compound annual rate over the past 14 years.

Based on SEC 10-K filings.

Key Data Points

High Piotroski F-Score: 8/9 (strong financial health signals)
Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
High earnings quality (cash-backed earnings)
Strong return on equity: 32.6%

Data sourced from SEC EDGAR filings. Not investment advice.

Item	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011
Revenue	$48.2B	$48.3B	$45.0B	$46.2B	$46.4B	$42.5B	$20.8B	$19.4B	$20.8B	$15.9B	$16.4B	$15.9B	$21.2B	$19.5B	$21.2B
Cost of Revenue	$13.9B	$14.0B	$10.7B	$10.1B	$9.9B	$11.8B	$6.0B	$5.0B	$6.0B	$3.9B	$4.6B	$3.9B	$5.6B	$5.3B	$5.6B
Gross Profit	-	-	-	-	-	$30.7B	$16.1B	$14.7B	$14.7B	$12.7B	$11.9B	$11.9B	$13.0B	$15.6B	$15.6B
SG&A Expense	$7.3B	$8.4B	$7.8B	$7.8B	$7.7B	$7.7B	$4.8B	$5.0B	$4.8B	$4.8B	$4.9B	$4.8B	$4.2B	$3.7B	$4.2B
R&D Expense	$10.0B	$11.2B	$9.3B	$9.5B	$10.2B	$10.0B	$6.5B	$5.0B	$6.5B	$4.5B	$3.7B	$4.5B	$3.8B	$3.6B	$3.8B
Interest Expense	-	-	$1.2B	$1.2B	$1.3B	$1.4B	$196.0M	$167.0M	$196.0M	$203.0M	$199.0M	$203.0M	$145.0M	$145.0M	$145.0M
Income Tax	$2.3B	$554.0M	$400.0M	$1.4B	$1.1B	$2.1B	$4.2B	$1.4B	$4.2B	$352.0M	$311.0M	$352.0M	$1.7B	$1.6B	$1.7B
Net Income	$7.1B	-$8.9B	$8.0B	$6.3B	$7.0B	-$9.0B	$1.0B	$4.5B	$1.0B	$2.0B	$2.6B	$2.0B	$3.7B	$3.1B	$3.7B
EPS (Basic)	$3.47	-$4.41	$3.88	$2.97	$3.15	-$3.99	$0.61	$2.67	$0.94	$1.21	$1.56	$1.17	$2.18	$1.80	$5.35
EPS (Diluted)	$3.46	-$4.41	$3.86	$2.95	$3.12	-$3.99	$0.61	$2.65	$0.93	$1.20	$1.54	$1.16	$2.16	$1.79	$5.34
Shares Outstanding	2.0B	2.0B	2.1B	2.1B	2.2B	2.3B	1.7B	1.7B	1.7B	1.7B	1.7B	1.7B	1.7B	1.7B	2.0B
Gross Margin	-	-	-	-	-	72.3%	77.5%	75.6%	70.7%	79.7%	72.9%	75.2%	61.3%	80.3%	73.7%
Profit Margin	14.6%	-18.5%	17.8%	13.7%	15.1%	-21.2%	4.9%	22.9%	4.9%	12.6%	15.6%	12.6%	17.5%	15.9%	17.5%

Other Financial Statements

Balance Sheet Cash Flow Statement All Financial Data

Scores & Analysis

Piotroski F-Score Altman Z-Score Financial Ratios

Bristol Myers Squibb Profile All Financial Data

Item

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

FY2012

FY2011

Revenue

$48.2B

$48.3B

$45.0B

$46.2B

$46.4B

$42.5B

$20.8B

$19.4B

$20.8B

$15.9B

$16.4B

$15.9B

$21.2B

$19.5B

$21.2B

Cost of Revenue

$13.9B

$14.0B

$10.7B

$10.1B

$9.9B

$11.8B

$6.0B

$5.0B

$6.0B

$3.9B

$4.6B

$3.9B

$5.6B

$5.3B

$5.6B

Gross Profit

$30.7B

$16.1B

$14.7B

$12.7B

$11.9B

$13.0B

$15.6B

SG&A Expense

$7.3B

$8.4B

$7.8B

$7.7B

$4.8B

$5.0B

$4.8B

$4.9B

$4.8B

$4.2B

$3.7B

$4.2B

R&D Expense

$10.0B

$11.2B

$9.3B

$9.5B

$10.2B

$10.0B

$6.5B

$5.0B

$6.5B

$4.5B

$3.7B

$4.5B

$3.8B

$3.6B

$3.8B

Interest Expense

$1.2B

$1.3B

$1.4B

$196.0M

$167.0M

$196.0M

$203.0M

$199.0M

$203.0M

$145.0M

Income Tax

$2.3B

$554.0M

$400.0M

$1.4B

$1.1B

$2.1B

$4.2B

$1.4B

$4.2B

$352.0M

$311.0M

$352.0M

$1.7B

$1.6B

$1.7B

Net Income

$7.1B

-$8.9B

$8.0B

$6.3B

$7.0B

-$9.0B

$1.0B

$4.5B

$1.0B

$2.0B

$2.6B

$2.0B

$3.7B

$3.1B

$3.7B

EPS (Basic)

$3.47

-$4.41

$3.88

$2.97

$3.15

-$3.99

$0.61

$2.67

$0.94

$1.21

$1.56

$1.17

$2.18

$1.80

$5.35

EPS (Diluted)

$3.46

-$4.41

$3.86

$2.95

$3.12

-$3.99

$0.61

$2.65

$0.93

$1.20

$1.54

$1.16

$2.16

$1.79

$5.34

Shares Outstanding

2.0B

2.1B

2.2B

2.3B

1.7B

2.0B

Gross Margin

72.3%

77.5%

75.6%

70.7%

79.7%

72.9%

75.2%

61.3%

80.3%

73.7%

Profit Margin

14.6%

-18.5%

17.8%

13.7%

15.1%

-21.2%

4.9%

22.9%

4.9%

12.6%

15.6%

12.6%

17.5%

15.9%

17.5%